openPR Logo
Press release

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

06-06-2025 10:21 AM CET | Health & Medicine

Press release from: IMARC Group

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035

According to the latest report by IMARC Group, the top 7 (US, EU4, UK, and Japan) pneumonia markets are expected to exhibit a CAGR of 5.16% during 2025-2035.

The pneumonia market is witnessing significant growth, driven by the advances in diagnostics, treatment, and prevention. Pneumonia forms one of the main causes of illness and death worldwide, affecting vulnerable groups such as children under five and the elderly. Increased incidence of pneumonia and increased healthcare awareness are reacting to increased demand for its treatment and prevention.

One of the other few factors driving demand is the development and adoption of advanced diagnostic tools. Rapid diagnostic tests and molecular assays have revolutionized pneumonia detection by providing quick and accurate diagnosis and, consequently, timely treatment. These advances are particularly useful in resource-limited settings since early diagnosis can substantially reduce the burden of complications and their associated healthcare costs.

Request for a sample of this report: https://www.imarcgroup.com/pneumonia-market/requestsample

Another evolving area of therapeutics for pneumonia is antibiotic therapy with respect to the developing issues on antibiotic resistance. This will guarantee that bacterial pneumonia will be kept to a minimum. On the other hand, support therapies like oxygen supplementation and physiotherapy work wonders in enhancing patient recovery and outcomes.

Further backing of the market comes from pneumonia cases increasing among immunocompromised patients, either with chronic diseases or those receiving treatments that are immunosuppressive in nature. This particular population requires specialized treatment regimes and continued monitoring, therefore, providing a stimulus to the said market for healthcare services for pneumonia.

The evolution of telemedicine and digital health platforms has improved access to pneumonia care in underserved and far-flung areas. These platforms allow virtual consultations, remote monitoring, and timely medical advice to promote continuity of care and to reduce hospital admissions.

Ask the Analyst for Customization and Get Full Insights with TOC: https://www.imarcgroup.com/request?type=report&id=8133&flag=E

This report also provides a detailed analysis of the current pneumonia marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Competitive Landscape With Key Players:

The competitive landscape of the pneumonia market has been studied in the report with the detailed profiles of the key players operating in the market.

AbbVie
Merck & Co., Inc.
Shionogi Inc.
Paratek Pharmaceuticals, Inc.
Nabriva Therapeutics plc
APTARION Biotech AG
Biotest AG

IMARC Group Offers Other Reports:

Type 2 Diabetes Market:https://www.imarcgroup.com/type-2-diabetes-market

Klebsiella Pneumoniae Infections Market: https://www.imarcgroup.com/klebsiella-pneumoniae-infections-market

Hand Eczema Market:https://www.imarcgroup.com/hand-eczema-market

Cardiotoxicity Market:https://www.imarcgroup.com/cardiotoxicity-market

Inflammatory Bowel Disease Market:https://www.imarcgroup.com/inflammatory-bowel-disease-market

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumonia Market Size, Epidemiology Trends, Treatment, and Forecast to 2035 here

News-ID: 4054802 • Views: …

More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insights
India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market. Market Size & Future Growth Potential: The India seafood…
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025-2033
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025: Base Year: 2024 Historical Years: 2019-2024 Forecast Years: 2025-2033 Market Size in 2024: USD 2.50 Billion Market Size in 2033: USD 5.90 Billion Market Growth Rate (CAGR) 2025-2033: 10.03% How Big is the India Mutual Funds Industry? The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033. Request…
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Expanding at a CAGR of 8.09%
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview: The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, Project Economics
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay. IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…

All 5 Releases


More Releases for Pneumonia

Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776 Key Market Drivers • Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market? The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview: The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…